BiomX Inc. — Director's Dealing 2025

Apr 21, 2025

SEC Form 4/A — Form 4/A

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2025-04-14

Reporting Person: Solomon Jonathan Eitan (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-14	Common Stock	A	126748	—	Acquired	126748	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-14	Common Stock Options - right to Buy	$0.538	A	380500	Acquired	2035-04-14	Common Stock (380500)	Direct

Footnotes

F1: Represents a grant of 126,748 Restricted Stock Units ("RSUs"). The RSUs are immediately vested and convert into the Issuer's shares of common stock on a one-for-one basis.

F2: The options vest and become exercisable over four years, with 25% of the shares of common stock subject to the option vesting on April 14, 2026, and the reminder vesting in 12 equal quarterly installments over three years.